loading

Hepion Pharmaceuticals Inc Stock (HEPA) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
50.21%
5.1823
10.41 10.66 14.17 13.21
Interest Income/Expense
80.38%
0.00435
0.00241 0.00238 0.00235 0.00232
Operating Income/Loss
50.21%
-5.1823
-10.41 -10.66 -14.17 -13.21
Income/Loss From Continuing Operations Before Tax
49.23%
-5.8231
-11.47 -10.53 -14.08 -13.26
Income Tax Expense/Benefit
625.94%
-2.9693
-0.409 - - -
Income/Loss From Continuing Operations After Tax
74.20%
-2.8538
-11.06 -10.53 -14.08 -13.26
Net Income/Loss
74.20%
-2.8538
-11.06 -10.53 -14.08 -13.26
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
3,391%
5.0725
0.1453 3.8383 3.8265 3.8115
Diluted Average Shares
3,391%
5.0725
0.1453 3.8383 3.8265 3.8115
Basic Earnings Per Share
76.86%
-0.56
-2.42 -2.74 -3.68 -3.48
Diluted Earnings Per Share
76.86%
-0.56
-2.42 -2.74 -3.68 -3.48
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$18.94
price down icon 1.35%
$75.45
price up icon 0.87%
$43.39
price up icon 3.19%
$378.13
price up icon 0.30%
$206.16
price up icon 7.31%
$120.72
price up icon 1.84%
Cap:     |  Volume (24h):